Urinary incontinence in cerebral infarction is mainly due to active treatment of cerebral infarction, anti-inflammatory treatment if necessary, prevention of urinary tract infection, and active acupuncture treatment or rehabilitation therapy. Urinary incontinence in cerebral infarction is caused by the infarct foci of cerebral infarction that damage the urinary center, which is seen in the paracentral lobule, also clinically known as lobar infarction, mostly caused by hypotension or severe hypovolemia, mainly due to volume expansion treatment, intravenous infusion of 706 plasma substitute. For patients with ultra-early stage, if thrombolysis is suitable, intravenous thrombolytic therapy should be given as much as possible; if thrombolysis is not suitable or beyond the time window of thrombolytic therapy, aspirin antiplatelet aggregation therapy should be given as much as possible, along with neuroprotective and circulation improvement therapy. Neuroprotective drugs include edaravone, cytarabine, and cerebroprotein hydrolysate, and drugs to improve blood circulation are usually used in clinical practice, such as sulforaphane, vincristine, and chuanxiongzine.